Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1183 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Unknown  Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
3 Completed
Has Results
Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo
4 Completed Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
5 Recruiting Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells
Condition: Leukoencephalopathy
Interventions: Biological: PyVST;   Other: No Intervention
6 Completed Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Conditions: Human Immunodeficiency Virus Infection (HIV);   Sexually Transmitted Disease (STD)
Interventions: Behavioral: BRO HIV Risk Reduction Intervention;   Behavioral: Health Promotion Intervention
7 Recruiting Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
8 Completed Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
Conditions: Human Immunodeficiency Virus Infection;   Sexually Transmitted Diseases
Interventions: Behavioral: Men Making a Difference HIV/STD Risk Reduction Intervention;   Behavioral: Health Promotion Control
9 Terminated Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
10 Terminated
Has Results
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention: Drug: mefloquine
11 Recruiting Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers
Condition: Human Immunodeficiency Virus
Interventions: Drug: TMB-607;   Drug: Placebo
12 Recruiting Treatment of Adult-Onset Immunodeficiency With Bortezomib
Condition: Adult-onset Immunodeficiency
Interventions: Drug: Bortezomib;   Drug: Cyclophosphamide
13 Recruiting Optimization of Darunavir Therapy and Dosage Recommendations
Condition: Human Immunodeficiency Virus I Infection
Intervention: Drug: Darunavir
14 Enrolling by invitation Neuropsychological Outcomes of Internationally-Adopted Children Who Are Perinatally-Infected With Human Immunodeficiency Virus
Condition: HIV/AIDS
Intervention: Other: Neuropsychological testing
15 Not yet recruiting Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania
Conditions: Human Immunodeficiency Virus;   Diabetes Mellitus, Type 2;   Hypertension
Interventions: Diagnostic Test: Blood glucose and blood pressure testing;   Behavioral: Diet and lifestyle counseling;   Drug: DM/HTN medications as needed
16 Not yet recruiting Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Conventional dolutegravir 10 mg tablet;   Drug: Conventional dolutegravir 50 mg tablet;   Drug: Dispersible dolutegravir 5 mg tablet;   Drug: Conventional dolutegravir 25 mg tablet
17 Recruiting Impact of Recombinant Human Growth Hormone on HIV Persistence
Conditions: Human Immunodeficiency Virus;   Growth Hormone Treatment
Intervention: Drug: Somatotropin (Human)
18 Not yet recruiting MAMAS: Mentoring Adolescent Mothers at School
Conditions: Human Immunodeficiency Virus;   Herpes Simplex Type II;   Chlamydia;   Gonorrhea;   Trichomonas Vaginitis
Intervention: Behavioral: Mentoring Adolescent Mothers at School (MAMAS)
19 Not yet recruiting Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir;   Drug: Lamivudine;   Drug: Dolutegravir + Lamivudine FDC Formulation 1;   Drug: Dolutegravir + Lamivudine FDC Formulation 2
20 Recruiting Support for Perinatal Adherence and Depression
Conditions: Human Immunodeficiency Virus;   Depression
Intervention: Behavioral: Integrating Nuanced Support for Perinatal adherence and Depression

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.